New Edge Advisors, LLC Pacira Bio Sciences, Inc. Transaction History
New Edge Advisors, LLC
- $15 Billion
- Q3 2024
A detailed history of New Edge Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 100 shares of PCRX stock, worth $2,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$2,603
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PCRX
# of Institutions
256Shares Held
48.3MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$208 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$138 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$84.9 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$52.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$51.5 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.19B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...